Cited 1 times in 
Cited 0 times in 
Correspondence to editorial on "Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C"
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Ryu, Tom | - |
| dc.contributor.author | Chang, Young | - |
| dc.contributor.author | Kim, Seung Up | - |
| dc.contributor.author | Jang, Jae Young | - |
| dc.date.accessioned | 2025-11-11T05:01:05Z | - |
| dc.date.available | 2025-11-11T05:01:05Z | - |
| dc.date.created | 2025-08-19 | - |
| dc.date.issued | 2025-04 | - |
| dc.identifier.issn | 2287-2728 | - |
| dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/208613 | - |
| dc.format | application/pdf | - |
| dc.language | English | - |
| dc.publisher | Korean Association for the Study of the Liver | - |
| dc.relation.isPartOf | CLINICAL AND MOLECULAR HEPATOLOGY | - |
| dc.relation.isPartOf | CLINICAL AND MOLECULAR HEPATOLOGY | - |
| dc.title | Correspondence to editorial on "Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C" | - |
| dc.type | Article | - |
| dc.contributor.googleauthor | Ryu, Tom | - |
| dc.contributor.googleauthor | Chang, Young | - |
| dc.contributor.googleauthor | Kim, Seung Up | - |
| dc.contributor.googleauthor | Jang, Jae Young | - |
| dc.identifier.doi | 10.3350/cmh.2025.0179 | - |
| dc.relation.journalcode | J00557 | - |
| dc.identifier.eissn | 2287-285X | - |
| dc.identifier.pmid | 39993416 | - |
| dc.subject.keyword | Direct-acting antivirals | - |
| dc.subject.keyword | Liver fibrosis | - |
| dc.subject.keyword | Regression | - |
| dc.subject.keyword | Dyslipidemia | - |
| dc.subject.keyword | Diabetes mellitus | - |
| dc.contributor.affiliatedAuthor | Kim, Seung Up | - |
| dc.identifier.scopusid | 2-s2.0-105003002533 | - |
| dc.identifier.wosid | 001490248200011 | - |
| dc.citation.volume | 31 | - |
| dc.citation.number | 2 | - |
| dc.citation.startPage | e203 | - |
| dc.citation.endPage | e205 | - |
| dc.identifier.bibliographicCitation | CLINICAL AND MOLECULAR HEPATOLOGY, Vol.31(2) : e203-e205, 2025-04 | - |
| dc.identifier.rimsid | 88635 | - |
| dc.type.rims | ART | - |
| dc.description.journalClass | 1 | - |
| dc.description.journalClass | 1 | - |
| dc.subject.keywordAuthor | Direct-acting antivirals | - |
| dc.subject.keywordAuthor | Liver fibrosis | - |
| dc.subject.keywordAuthor | Regression | - |
| dc.subject.keywordAuthor | Dyslipidemia | - |
| dc.subject.keywordAuthor | Diabetes mellitus | - |
| dc.subject.keywordPlus | CIRRHOSIS | - |
| dc.type.docType | Letter | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
| dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.